RE:Many of these clinical test resultsAggrastat and Prexxartan patents expire around the same time in 2023--instead of conducting trials on these drugs, he needs to be looking to expanding the product line...which he isn't doing. Friessen's mismanagemnt is getting comical--blows through a mountain of cash with nothing to show for it--and is now conducting trials on patent-expiring drugs.